Moderna, Inc.MRNANASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank78
Studio
Year-over-Year Change

Price-to-earnings ratio

Percentile
P78
Within normal range
vs 3Y Ago
-0.5x
Contraction
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
2025-4.07+9.3%
2024-4.48+44.4%
2023-8.06-195.2%
20228.46+0.9%
20218.39+115.7%
2020-53.33-323.6%
2019-12.59+3.5%
2018-13.05+52.2%
2017-27.33-395.6%
2016-5.51-